Major Estimate Revision • Apr 30
Consensus revenue estimates decrease by 14%, EPS upgraded The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from kr8.30m to kr7.10m. EPS estimate increased from -kr1.02 to -kr0.71 per share. Chemicals industry in Sweden expected to see average net income growth of 50% next year. Consensus price target down from kr2.30 to kr1.50. Share price was steady at kr1.01 over the past week. Ankündigung • Apr 25
Svenska Aerogel Holding AB (publ), Annual General Meeting, May 27, 2026 Svenska Aerogel Holding AB (publ), Annual General Meeting, May 27, 2026, at 10:00 W. Europe Standard Time. Location: writing & reading room, elite grand hotel in gavle, kyrkogatan 28, 803 11, gavle Sweden Reported Earnings • Apr 21
First quarter 2026 earnings: EPS exceeds analyst expectations while revenues lag behind First quarter 2026 results: kr0.26 loss per share (improved from kr0.91 loss in 1Q 2025). Revenue: kr1.12m (down 18% from 1Q 2025). Net loss: kr7.65m (loss narrowed 12% from 1Q 2025). Revenue missed analyst estimates by 14%. Earnings per share (EPS) exceeded analyst estimates by 7.1%. Revenue is forecast to grow 54% p.a. on average during the next 3 years, compared to a 1.2% growth forecast for the Chemicals industry in Sweden. Major Estimate Revision • Apr 16
Consensus revenue estimates fall by 19% The consensus outlook for revenues in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from kr10.2m to kr8.30m. Forecast losses increased from -kr0.99 to -kr1.02 per share. Chemicals industry in Sweden expected to see average net income growth of 50% next year. Consensus price target down from kr2.50 to kr2.30. Share price fell 2.8% to kr1.38 over the past week. Breakeven Date Change • Apr 07
No longer forecast to breakeven The analyst covering Svenska Aerogel Holding no longer expects the company to break even during the foreseeable future. The company was expected to make a profit of kr16.7m in 2028. New forecast suggests the company will make a loss of kr20.7m in 2028. Recent Insider Transactions • Mar 23
Independent Director recently bought kr79k worth of stock On the 19th of March, Jim Wennerlid bought around 50k shares on-market at roughly kr1.59 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought kr233k more in shares than they have sold in the last 12 months. Reported Earnings • Feb 18
Full year 2025 earnings released: kr1.10 loss per share (vs kr3.83 loss in FY 2024) Full year 2025 results: kr1.10 loss per share (improved from kr3.83 loss in FY 2024). Revenue: kr4.71m (up 82% from FY 2024). Net loss: kr31.9m (loss narrowed 6.8% from FY 2024). Reported Earnings • Oct 26
Third quarter 2025 earnings released: kr0.24 loss per share (vs kr0.95 loss in 3Q 2024) Third quarter 2025 results: kr0.24 loss per share (improved from kr0.95 loss in 3Q 2024). Revenue: kr901.0k (up 60% from 3Q 2024). Net loss: kr7.13m (loss narrowed 21% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings. New Risk • Sep 08
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 121% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr28m free cash flow). Share price has been highly volatile over the past 3 months (18% average weekly change). Shareholders have been substantially diluted in the past year (121% increase in shares outstanding). Revenue is less than US$1m (kr4.2m revenue, or US$447k). Market cap is less than US$10m (kr43.3m market cap, or US$4.62m). Recent Insider Transactions • Sep 03
Independent Director recently bought kr77k worth of stock On the 28th of August, Jim Wennerlid bought around 37k shares on-market at roughly kr2.08 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Reported Earnings • Sep 02
Second quarter 2025 earnings released: kr0.41 loss per share (vs kr0.66 loss in 2Q 2024) Second quarter 2025 results: kr0.41 loss per share. Revenue: kr1.26m (up 130% from 2Q 2024). Net loss: kr8.45m (loss widened 36% from 2Q 2024). Ankündigung • Aug 07
Svenska Aerogel Holding AB (Publ) Appoints Henrik Andersson as Chief Financial Officer, Effective September 1, 2025 Svenska Aerogel Holding AB (publ) has nominated Henrik Andersson as Chief Financial Officer (CFO), effective September 1, 2025. He has extensive experience in the field, including serving as Group and Business Controller at international industrial companies. Henrik holds a Master's Degree in Business Administration and has extensive experience in the field. He has served as Group and Business Controller at companies such as IPCO Sweden AB and Sandvik Coromant. New Risk • Jul 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Swedish stocks, typically moving 9.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr20m free cash flow). Earnings have declined by 0.4% per year over the past 5 years. Revenue is less than US$1m (kr3.5m revenue, or US$361k). Market cap is less than US$10m (kr16.9m market cap, or US$1.75m). Minor Risk Share price has been volatile over the past 3 months (9.3% average weekly change). New Risk • Jul 03
New major risk - Revenue and earnings growth Earnings have declined by 0.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr20m free cash flow). Earnings have declined by 0.4% per year over the past 5 years. Revenue is less than US$1m (kr3.5m revenue, or US$366k). Market cap is less than US$10m (kr14.4m market cap, or US$1.51m). Ankündigung • Jun 24
Svenska Aerogel Holding AB (Publ) Announces Resignation of Elin Lovén as Chief Financial Officer Svenska Aerogel announced that the Company's Chief Financial Officer, Elin Lovén, has informed the Company of her decision to leave her position to pursue a new opportunity. Elin Lovén has served as CFO since 2022 and plans to remain in her role through the end of December 2025 to ensure a smooth transition. Reported Earnings • May 10
First quarter 2025 earnings released: kr0.91 loss per share (vs kr1.53 loss in 1Q 2024) First quarter 2025 results: kr0.91 loss per share (improved from kr1.53 loss in 1Q 2024). Net loss: kr8.65m (loss narrowed 23% from 1Q 2024). Revenue is forecast to grow 62% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Sweden. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings. New Risk • May 10
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -kr20m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr20m free cash flow). Share price has been highly volatile over the past 3 months (18% average weekly change). Revenue is less than US$1m (kr3.5m revenue, or US$359k). Market cap is less than US$10m (kr17.1m market cap, or US$1.76m). Minor Risk Currently unprofitable and not forecast to become profitable over next 3 years (kr8.8m net loss in 3 years). Ankündigung • Apr 24
Svenska Aerogel Holding AB (publ), Annual General Meeting, May 27, 2025 Svenska Aerogel Holding AB (publ), Annual General Meeting, May 27, 2025, at 10:00 W. Europe Standard Time. Location: in the theatre hall, elite grand hotel, gavle, kyrkogatan 28, 803 11 gavle. Sweden Ankündigung • Mar 26
Svenska Aerogel Holding AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 24.583127 million. Svenska Aerogel Holding AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 24.583127 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 10,925,834
Price\Range: SEK 2.25
Transaction Features: Rights Offering Ankündigung • Feb 28
Svenska Aerogel Holding AB (publ) to Report Fiscal Year 2024 Results on Feb 27, 2025 Svenska Aerogel Holding AB (publ) announced that they will report fiscal year 2024 results on Feb 27, 2025 Ankündigung • Feb 27
Svenska Aerogel Holding AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 42.753267 million. Svenska Aerogel Holding AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 42.753267 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 19,001,452
Price\Range: SEK 2.25
Transaction Features: Rights Offering Major Estimate Revision • Dec 06
Consensus revenue estimates decrease by 61%, EPS upgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast fell from kr5.70m to kr2.20m. EPS estimate increased from -kr4.00 to -kr0.74 per share. Chemicals industry in Sweden expected to see average net income growth of 25% next year. Consensus price target down from kr38.00 to kr23.50. Share price fell 18% to kr8.30 over the past week. Price Target Changed • Dec 05
Price target decreased by 41% to kr23.50 Down from kr40.00, the current price target is provided by 1 analyst. New target price is 173% above last closing price of kr8.60. Stock is down 68% over the past year. The company is forecast to post a net loss per share of kr0.74 next year compared to a net loss per share of kr9.35 last year. Buy Or Sell Opportunity • Nov 25
Now 386% overvalued after recent price rise Over the last 90 days, the stock has risen 9,601% to kr13.00. The fair value is estimated to be kr2.68, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.9% over the last 3 years. Earnings per share has grown by 60%. For the next 3 years, revenue is forecast to grow by 64% per annum. Earnings are also forecast to grow by 40% per annum over the same time period. Reported Earnings • Nov 21
Third quarter 2024 earnings released: kr0.009 loss per share (vs kr0.021 loss in 3Q 2023) Third quarter 2024 results: kr0.009 loss per share (improved from kr0.021 loss in 3Q 2023). Net loss: kr9.02m (loss narrowed 16% from 3Q 2023). Revenue is forecast to grow 64% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Sweden. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings. New Risk • Nov 12
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Swedish stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr30m free cash flow). Share price has been highly volatile over the past 3 months (11% average weekly change). Shareholders have been substantially diluted in the past year (81% increase in shares outstanding). Revenue is less than US$1m (kr2.4m revenue, or US$219k). Market cap is less than US$10m (kr88.2m market cap, or US$8.13m). Minor Risk Currently unprofitable and not forecast to become profitable over next 3 years (kr23m net loss in 3 years). New Risk • Sep 30
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: kr101.0m (US$9.94m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr30m free cash flow). Shareholders have been substantially diluted in the past year (81% increase in shares outstanding). Revenue is less than US$1m (kr2.4m revenue, or US$233k). Market cap is less than US$10m (kr101.0m market cap, or US$9.94m). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (kr23m net loss in 3 years). Share price has been volatile over the past 3 months (9.0% average weekly change). Ankündigung • Sep 05
Svenska Aerogel Holding AB (publ) to Launch Quartzene®? Z-Slurry Product Svenska Aerogel announced the launch of their latest product, Quartzene Z-Slurry. This aqueous aerogel suspension is easily processed and pumpable, enhancing thermal insulation, improving fire safety, and reducing the weight of end products. It offers significant advantages for paint manufacturers as well as producers of fibrous products. Quartzene Z-Slurry is now available for purchase across Europe. Quartzene Z-Slur is a low-viscosity, aqueous aerogel suspended, featuring amorphous hydrophilic silica. The product ensures fast, dust-free incorporation, making it ideal for waterborne manufacturing processes such as the production of paints, coatings, and technical textiles and papers. Designed to facilitate downstream processing in factory settings, Quartzene Z- Slurry improves efficiency and reduces operational complexities. Summary of key features and benefits. Waterborne pumpable hydrophilic aerogel slurry: Quartzene Z-Slurry's low-viscosity nature ensures easy processing and pumpability, facilitating seamless integration into existing manufacturing workflows. No dusting: The suspension's formulation eliminates dusting, promoting a cleaner and safer working environment. Enhanced thermal insulation: With low thermal conductivity, Quartzene Z-Slur enhances the thermal insulation properties of end products, contributing to energy efficiency and sustainability. Improved fire safety: The aerogel suspension's inherent properties improve fire safety. Lightweight solution: By reducing the weight of products, Quartzene Z-SlUR offers manufacturers the ability to create lighter, more efficient end products. Reported Earnings • Aug 30
Second quarter 2024 earnings released: kr0.007 loss per share (vs kr0.027 loss in 2Q 2023) Second quarter 2024 results: kr0.007 loss per share (improved from kr0.027 loss in 2Q 2023). Net loss: kr6.24m (loss narrowed 49% from 2Q 2023). Revenue is forecast to grow 61% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Sweden. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings. Recent Insider Transactions • Jul 05
Chief Executive Officer recently bought kr149k worth of stock On the 3rd of July, Tor Norbakk bought around 1m shares on-market at roughly kr0.12 per share. This transaction amounted to 19% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Tor has been a buyer over the last 12 months, purchasing a net total of kr157k worth in shares. New Risk • Jun 04
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 137% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr38m free cash flow). Shareholders have been substantially diluted in the past year (137% increase in shares outstanding). Revenue is less than US$1m (kr2.1m revenue, or US$203k). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (kr28m net loss in 3 years). Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (kr123.6m market cap, or US$11.8m). Board Change • Jun 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Jim Wennerlid was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Ankündigung • May 10
Svenska Aerogel Holding AB (publ), Annual General Meeting, Jun 18, 2024 Svenska Aerogel Holding AB (publ), Annual General Meeting, Jun 18, 2024, at 10:00 W. Europe Standard Time. Location: in the teatersalen, elite grand hotel in gavle, kyrkogatan 28, 803 11 gavle, Sweden Reported Earnings • May 05
First quarter 2024 earnings released: kr0.01 loss per share (vs kr0.028 loss in 1Q 2023) First quarter 2024 results: kr0.01 loss per share. Net loss: kr11.2m (loss widened 1.7% from 1Q 2023). Revenue is forecast to grow 58% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Sweden. Reported Earnings • Mar 20
Full year 2023 earnings released: kr0.085 loss per share (vs kr0.15 loss in FY 2022) Full year 2023 results: kr0.085 loss per share. Net loss: kr44.1m (loss widened 9.5% from FY 2022). Revenue is forecast to grow 54% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Chemicals industry in Sweden. Ankündigung • Dec 23
Svenska Aerogel Holding AB (Publ) Introduces a New Key Customer in the Transport Segment As the year comes to a close, Svenska Aerogel is introducing a new key customer in the transport segment. The new key customer is a global, renowned supplier in the European automotive industry with substantial customer understanding and experience. Simultaneously, a key customer within the process industry has chosen Svenska Aerogel's solution over a competing technology. Reported Earnings • Nov 27
Third quarter 2023 earnings released: kr0.021 loss per share (vs kr0.031 loss in 3Q 2022) Third quarter 2023 results: kr0.021 loss per share. Net loss: kr10.7m (loss widened 40% from 3Q 2022). Reported Earnings • Aug 31
Second quarter 2023 earnings released: kr0.027 loss per share (vs kr0.047 loss in 2Q 2022) Second quarter 2023 results: kr0.027 loss per share. Revenue: kr292.0k (down 13% from 2Q 2022). Net loss: kr12.2m (loss widened 4.9% from 2Q 2022). Recent Insider Transactions Derivative • May 24
Chief Executive Officer exercised options to buy kr1.0m worth of stock. On the 16th of May, Tor Norbakk exercised options to buy 4m shares at a strike price of around kr0.22, costing a total of kr822k. Company insiders have collectively sold kr2.7m more than they bought, via options and on-market transactions in the last 12 months. Reported Earnings • Feb 19
Full year 2022 earnings released: kr0.10 loss per share (vs kr0.31 loss in FY 2021) Full year 2022 results: kr0.10 loss per share (improved from kr0.31 loss in FY 2021). Revenue: kr6.35m (up 255% from FY 2021). Net loss: kr40.3m (flat on FY 2021). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has fallen by 34% per year, which means it is significantly lagging earnings. Recent Insider Transactions • Dec 18
Chief Executive Officer recently sold kr1.8m worth of stock On the 15th of December, Tor Norbakk sold around 2m shares on-market at roughly kr0.74 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Tor's only on-market trade for the last 12 months. Reported Earnings • Aug 19
Second quarter 2022 earnings released: kr0.047 loss per share (vs kr0.09 loss in 2Q 2021) Second quarter 2022 results: kr0.047 loss per share. Net loss: kr11.6m (loss widened 4.1% from 2Q 2021). Board Change • Jul 31
High number of new directors Independent Director Petra Einarsson was the last director to join the board, commencing their role in 2021. Reported Earnings • Apr 27
Full year 2021 earnings released: kr0.31 loss per share (vs kr0.52 loss in FY 2020) Full year 2021 results: kr0.31 loss per share. Net loss: kr40.6m (loss widened 8.5% from FY 2020). Board Change • Apr 27
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. Independent Director Marten Hellberg is the most experienced director on the board, commencing their role in 2018. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 17
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Full year 2021 results: kr0.31 loss per share (up from kr0.52 loss in FY 2020). Net loss: kr40.6m (loss widened 8.5% from FY 2020). Revenue missed analyst estimates by 32%. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 20
Third quarter 2021 earnings released: kr0.062 loss per share (vs kr0.11 loss in 3Q 2020) Third quarter 2021 results: Net loss: kr8.54m (flat on 3Q 2020). Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 43% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 28
Second quarter 2021 earnings released: kr0.09 loss per share (vs kr0.13 loss in 2Q 2020) Second quarter 2021 results: Net loss: kr11.2m (loss widened 9.8% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings. Recent Insider Transactions Derivative • Jul 01
Chief Executive Officer exercised options to buy kr130k worth of stock. On the 28th of June, Tor Norbakk exercised options to buy 148k shares at a strike price of around kr0.64, costing a total of kr94k. This transaction amounted to 12% of their direct individual holding at the time of the trade. Since December 2020, Tor's direct individual holding has increased from 1.03m shares to 1.18m. Company insiders have collectively bought kr210k more than they sold, via options and on-market transactions, in the last 12 months. Reported Earnings • May 11
First quarter 2021 earnings released: kr0.082 loss per share (vs kr0.18 loss in 1Q 2020) First quarter 2021 results: Net loss: kr9.43m (flat on 1Q 2020). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 40% per year, which means it is significantly lagging earnings. Recent Insider Transactions Derivative • Apr 02
Chief Executive Officer exercised options to buy kr139k worth of stock. On the 27th of March, Tor Norbakk exercised options to buy 148k shares at a strike price of around kr0.58, costing a total of kr86k. This transaction amounted to 14% of their direct individual holding at the time of the trade. Since December 2020, Tor has owned 1.03m shares directly. Company insiders have collectively bought kr106k more than they sold, via options and on-market transactions, in the last 12 months. Is New 90 Day High Low • Jan 18
New 90-day high: kr1.10 The company is up 4.0% from its price of kr1.06 on 20 October 2020. The Swedish market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period. Reported Earnings • Nov 22
Third quarter 2020 earnings released: kr0.11 loss per share Third quarter 2020 results: Net loss: kr8.59m (loss widened 8.5% from 3Q 2019). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 50% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Nov 05
New 90-day low: kr0.74 The company is down 41% from its price of kr1.25 on 07 August 2020. The Swedish market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 27% over the same period. Is New 90 Day High Low • Oct 21
New 90-day low: kr0.84 The company is down 34% from its price of kr1.28 on 23 July 2020. The Swedish market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 34% over the same period. 
